LIVN News and Press, LivaNova PLC From 05/04/22

LivaNova PLC press release (NASDAQ:LIVN): Q1 Non-GAAP EPS of $0.48 in-line. Revenue of $240.2M (-3.0% Y/Y) beats by $8.63M. LivaNova continues to expect worldwide net sales for full-year 2022 to grow between 3 and 5 percent on a constant-currency basis after excluding the impact of the Heart ...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended March 31, 2022. Financial Summary and Highlights 1 Worldwide sales were $240.2 million, a decrease of 3.0 percent on a reported bas...

Medical device maker LivaNova (NASDAQ:LIVN) started a targeted commercial launch for its Essenz Patient Monitor after receiving required regulatory approvals. According to the company, the monitoring system improves clinical efficiency by displaying data and parameters to patients through an ...

Intuitive monitor featuring patient-tailored approach is now in clinical use in select centers in U.S. and Europe LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today announced receipt of regulatory approvals and the start of a targe...

Goldman Sachs has weighed in on the impact of macro factors on the MedTech stocks as the COVID recovery develops into a potential tailwind for a sector hurt by the pandemic’s impact on medical procedures. As part of the analysis, the firm has downgraded Baxter International (NYSE:BAX -...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its first-quarter 2022 results on Wednesday, May 4, 2022 at 1 p.m. London time (8 a.m. EDT). The Company will release its first-quarter 2022 results prior to t...

Harris Associates’ 13F portfolio value increased from $62.77B to $64.23B this quarter. They increased Fiserv and Visa while dropping Alibaba Group Holdings and Cenovus Energy. The top three positions are Alphabet, Fiserv, and Bank of America, and they add up to ~16% of the ...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the 250th unipolar depression patient has been implanted in the RECOVER clinical study , “A P r ospective, Multi-c e nter, Randomized C ontrolled Blinded Trial...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips In recent years, it hasn’t been a good time to push David Einhorn stocks. In 2021, Greenlight Capital’s holdings delivered 11.9% to its limited partners, 16.8 percentage points less than the S&P 500 . ...

David Einhorn's 13F stock portfolio value increased from $1.49B to $1.75B this quarter. Greenlight increased Capri Holdings, ODP Group, Livanova, & Victoria’s Secret while reducing Twitter, Concentrix, & EchoStar. They also added Global Payments while dropping AerCap an...